1. Ananyeva NM, Lacroix-Desmazes S, Hauser CA, Shima M, Ovanesov MV, Khrenov AV & Saenko EL
Inhibitors in hemophila A: mechanisms of inhibition, management and perspectives.
Blood Coagul. Fibrinolysis 15 (2004) 109-124

2. Baker-Glenn C, Ancliff R & Gouverneur V
A biocatalytic route to enantioenriched, sulfanyl aldol products.
Tetrahedron 60 (2004) 7607-7619

3. Baranovskii AG, Buneva VN & Nevinsky GA
Human deoxyribonucleases.
Biochemistry Moscow 69 (2004) 587-601

4. Baranovskii AG, Odintsova ES, Buneva VN, Doronin BM & Nevinsky GA
Comparison of enzymatic properties of DNA-abzymes and human DNAses.
Nucleosides Nulceotides Nucleic Acids 23 (2004) 1053-1056

5. Benedetti F, Berti F, Brady K, Colombatti A, Pauletto A, Pucillo C & Thomas NR
An unprecedented catalytic motif revealed in the model structure of amide hydrolyzing antibody 312d6.
Chembiochem 5 (2004) 129-131

6. Black KA, Leach AG, Kalani MY & Houk KN
Antibody-catalyzed oxy-cope rearrangement: mechanism and origins of catalysis and stereoselectivity from DFT quantum mechanisms and flexible docking.
J. Am. Chem. Soc. 26 (2004) 9695-9708

7. Blackburn GM, Rickard JH, Cesaro-Tadic S, Lagos D, Mekhalfia A, Partridge L & Pluckthun A
Passive and catalytic antibodies and drug delivery.
Pure Appl. Chem. 76 (2004) 983-989

8. Britt BM
Understanding enzyme structure and function in terms of the shifting specificity model.
J. Biochem. Mol. Biol. 37 (2004) 394-401

9. Carrera MRA, Meijler MM & Janda KD
Cocaine pharmacology and current pharmacotherapies for its abuse.
Bioorg. Med. Chem. 12 (2004) 5019-5030

10. de Prada P & Landry DW
Production and characterization of anti-cocaine catalytic antibodies.
Methods Mol. Biol. 248 (2004) 495-501

11. Deng S, Bharat N, de Prada P & Landry DW
Substrate-assisted antibody catalysis.
Org. Biomol. Chem. 2 (2004) 288-290

12. Dickerson TJ, Yamamoto N & Janda KD
Antibody-catalyzed oxidative degradation of nicotin using riboflavin.
Bioorg. Med. Chem. 12 (2004) 4981-4987

13. Garcia-Junceda E, Garcia-Garcia JF, Bastida A & Fernandez-Mayoralas A
Enzymes in the synthesis of bioactive compounds: the prodigious decades.
Bioorg. Med. Chem. 12 (2004) 1817-1834

14. Girgenti E, Ricoux R & Mahy JP
Design and synthesis of a Mn(III)-porphyrin steroid conjugate used as a new cleavable affinity label: on the road to semi-synthetic catalytic antibodies.
Tetrahedron 60 (2004) 10049-10058

15. Goddard JP & Reymond JL
Enzymes assays for high-throughput screening.
Curr. Op. Biotechnol. 15 (2004) 314-322

16. Gorelick DA, Gardner EL & Xi ZX
Agents in development for the management of cocaine abuse.
Drugs 64 (2004) 1547-1573

17. Haney M & Kosten TR
Therapeutic vaccines for substance dependence.
Expert Rev. Vaccines 3 (2004) 11-18

18. Hu Y, Houk KN, Kikuchi K, Hotta K & Hilvert D
Nonspecific medium effects versus specific group positioning in the antibody and albumin catalysis of the base-promoted ring-opening reactions of benzisoxazoles.
J. Am. Chem. Soc. 126 (2004) 8197-8205

19. Ivanen DR, Kulminskaya AA, Shabalin KA, Isaeva-Ivanova LV, Ershova NA, Saveliev AN, Nevinsky GA & Neustroev KN
Catalytic properties of IgMs with amylolytic activity isolated from patients with multiple sclerosis.
Med. Sci. Monit. 10 (2004) 273-280

20. Kawamura-Konishi Y, Aoki T, Satoh N, Katagiri M & Suzuki H
Chemical modification of a catalytic antibody that accelerates insertion of a metal ion into porphyrin: essential amino acid residues for the catalytic activity.
J. Mol. Catal. B 31 (2004) 9-17

21. Larsen NA, de Prada P, Deng SX, Mittal A, Braskett M, Zhu X, Wilson IA & Landry DW
Crystallographic and biochemical analysis of cocaine-degrading antibody 15A10.
Biochemistry 43 (2004) 8067-8076

22. Leach AG, Houk KN & Reymond JL
Theoretical investigation of the origins of catalysis of a retro-Diels-Alder reaction by antibody 10F11.
J. Org. Chem. 69 (2004) 3683-3692

23. Lin Y, Shiraga S, Tsumuraya T, Fujii I , Matsumoto T, Kondo A & Ueda M
Isolation of novel catalytic antibody clones from combinatorial library displayed on yeast-cell surface.
J. Mol. Catal. B 28 (2004) 247-251

24. Lin Y, Shiraga S, Tsumuraya T, Matsumoto T, Kondo A, Fujii I & Ueda M
Comparison of two forms of catalytic antibody displayed on yeast-cell surface.
J. Mol. Catal. B 28 (2004) 241-246

25. Maggiotti V, Bahmanyar S, Reiter M, Resmini M, Houk K.N. & Gouverneur V
Unusual reversal of regioselectivity in antibody-mediated aldol additions with unsymmetrical methyl ketones.
Tetrahedron 60 (2004) 619-632

26. Manetsch R, Zheng L, Reymond MT, Woggon WD & Reymond JL
A catalytic antibody against a tocopherol cyclase inhibitor.
Chemistry 17 (2004) 2487-2506

27. Mitsuda Y, Hifumi E, Tsuruhata K, Fujinami H, Yamamoto N & Uda T
Catalytic antibody light chain capable of cleaving a chemokine receptor CCR-5 peptide with a high reaction rate constant.
Biotechnol. Bioeng. 86 (2004) 217-225

28. Mouratou B & Stetefeld J
Identification of functionally important residues in the pyridoxal-5'-phosphate-dependent catalytic antibody 15A9.
Biochemistry 43 (2004) 6612-6619

29. Muranova TA, Ruzheinikov SN, Higginbottom A, Clipson JA, Blackburn GM, Wentworth P, Datta A, Rice DW & Partridge LJ
Crystallization of a carbamatase catalytic antibody Fab fragment and its complex with a transition state analogue.
Acta Crystallog. D 60 (2004) 172-174

30. Nieva J & Wentworth P
The antibody-catalyzed water oxidation - a new chemical arm to immune defense?
Trends Biochem. Sci. 29 (2004) 274-278

31. Nishiyama Y, Bhatia G, Bangale Y, Planque S, Mitsuda Y, Taguchi H, Karle S & Paul S
Towards selective covalent inactivation of pathogenic antibodies: a phosphonate diester analog of vasoactive intestinal peptide that inhibits catalytic autoantibodies.
J. Biol. Chem. 279 (2004) 7877-7883

32. Ohara K, Manukata H, Hifumi E, Uda T & Matsuura K
Improvement of catalytic antibody activity by protease processing.
Biochem. Biophys. Res. Commun. 315 (2004) 612-616

33. Paul S, Karle S, Planque S, Tagushi H, Salas M, Nishiyama Y, Handy B, Hunter R, Edmundson A & Hanson C
Naturally occurring proteolytic antibodies: selective immunoglobulin M-catalyzed hydrolysis of HIV gp120.
J. Biol. Chem. 279 (2004) 39611-39619

34. Pessah N, Reznik M, Shamis M, Yantiri F, Xin H, Bowdish K, Shomron N, Ast G & Shabat D
Bioactivation of carbamate-based 20(S)-camptothecin prodrugs.
Bioorg. Med. Chem. 12 (2004) 1859-1866

35. Petrov K, Dion M, Hoffmann L, Dintinger T, Defontaine A & Tellier C
Bivalent Fv antibody fragments obtained by substitute the constant domains of a Fab fragment with heterotetrameric molybdopterin synthase.
J. Mol. Biol. 341 (2004) 1039-1048

36. Planque S, Bangale Y, Song XT, Karle S, Tagushi H, Poindexter B, Bick R, Edmundson A, Nishiyama Y & Paul S
Ontogeny of proteolytic immunity: IgM serine proteases.
J. Biol. Chem. 279 (2004) 14024-14032

37. Polosukhina DI, Kanyshkova TG, Doronin BM, Tvshkevich OB, Buneva VN, Boiko AN, Gusev EI, Favorova OO & Nevinsky GA
Hydrolysis of myelin basic protein by polyclonal catalytic IgGs from the sera of patients with multiple slerosis.
J. Cell Mol. Med. 8 (2004) 359-368

38. Ponomarenko NA, Durova OM, Vorobiev II, Suchkov SV & Gabibov AG
On the catalytic activity of autoantibodies in multiple sclerosis.
Dokl. Biochem. Biophys. 395 (2004) 120-123

39. Ricoux R, Lukowska E, Pezzotti F & Mahy JP
New activities of a catalytic antibody with a peroxidase activity.
Eur. J. Biochem. 271 (2004) 1277-1283

40. Rodriguez AC, Ramos AP, Hawkes GE, Berti F & Resmini M
Stereoselective synthesis of a novel pseudopeptide hapten for the generation of hydrolytic catalytic antibodies.
Tetrahedron Asymmetry 15 (2004) 1847-1855

41. Semenov DV, Kanyshkova TG, Karotaeva NA, Krasnorutskii MA, Kuznetsova IA, Buneva VN & Nevinsky GA
Catalytic nucleotide-hydrolyzing antibodies in milk and serum of clinically healthy human mothers.
Med. Sci. Monit. 10 (2004) 23-33

42. Shamis M, Lode HN & Shabat D
Bioactivation of self-immolative dendritic prodrugs by catalytic antibody 38C2.
J. Am. Chem. Soc. 126 (2004) 1726-1731

43. Shim H, Karlstrom A, Touami SM, Fuller RP & Barbas CF
Flow cytometry screening of aldolase catalytic antibodies.
Bioorg. Med. Chem Lett.. 14 (2004) 4065-4068

44. Sinha SC, Li LS, Miller GP, Dutta S, Rader C & Lerner RA
Prodrugs of dynemicin analogs for selective chemotherapy mediated by an aldolase catalytic Ab.
Proc. Natl. Acad. Sci. USA 101 (2004) 3095-3099

45. Sklute G, Oizerowich R, Shulman H & Keinan E
Antibody-catalyzed benzoin oxidation as a mechanism probe for nucleophilic catalysis by an active site lysine.
Chemistry 10 (2004) 2159-2165

46. Sonkaria S, Boucher G, Florez-Alvarez J, Said B, Hussain S, Ostler EL, Gul S, Thomas EW, Resmini M, Gallacher G & Brocklehurst
Evidence for lock-and-key character in an anti-phosphonate hydrolytic antibody catalytic site by non-reaction centre recognition: variation in substrate selectivity between an antiphosphonate antibody, an antiphosphate antibody and two hydrolytic enzymes.
Biochem. J. 381 (2004) 125-130

47. Takahashi-Ando N, Kakinuma H, Fujii I & Nishi Y
Directed evolution governed by controlling the molecular recognition between and abzyme and its haptenic transition-state analog.
J. Immunol. Methods 294 (2004) 1-14

48. Tanaka F, Fuller R, Shim H, Lerner RA & Barbas C
Evolution of aldolase antibodies in vitro: correlation of catalytic activity and reaction-based selection.
J. Mol. Biol. 343 (2004) 1007-1018

49. Uda Z & Hifumi E
Super catalytic antibodies and antigenase.
J. Biosci. Bioeng. 97 (2004) 143-152

50. Wei Y & Hecht MH
Enzyme-like proteins from an unselected library of designed amino acid sequences.
Protein Eng. Des. Sel. 17 (2004) 67-75

51. Xu Y, Yamamoto N & Janda KD
Catalytic antibodies: hapten design strategies and screening methods.
Bioorg. Med. Chem. 12 (2004) 5247-5268

52. Yin J, Mills JH @ Schultz PG
A catalysis-based selection for peroxidase antibodies with increased activity.
J. Am. Chem. Soc. 126 (2004) 3006-3007

53. Zhang Y, Li ZS, Sun M, Zheng QC & Sun CC
Molecular simulation studies of a selenium-containing scFv catalytic antibody that mimics glutathione peroxidase.
Biochim. Biophys. Acta (2004) in press

54. Zheng L, Baumann U & Reymond JL
Molecular mechanism of enantioselective proton transfer to carbon in catalytic antibody 14D9.
Proc. Natl. Acad. Sci. USA 101 (2004) 3387-3392

55. Zheng L, Goddard P, Baumann U & Reymond JL
Expression improvement and mechanistic study of the retro-Diels-Alderase catalytic antibody 10F11 by site-directed mutagenesis.
J. Mol. Biol. 341 (2004) 807-814